Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

1.325 -0.045 (-3.28%)
Streaming Delayed Price Updated: 11:10 AM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atai Life Sciences N.V.

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87 
Via Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29 
Via Benzinga
Roth Capital Reveals Top Psychedelic Picks in New Industry Report
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Investment banks are continuing to release positive coverage for psychedelic stocks and the latest report... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From April 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS: 
Via Benzinga
Jaden Smith Wants To Be A 'Psychedelics World Leader' After Trying Magic Mushrooms
In an interview with Complex to promote his clothing brand MSFTSrep, Jaden Smith talked about his experience with psychedelics and said he is looking to be a “psychedelics world leader.” 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33 
Via Benzinga
EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments
ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments. 
Via Benzinga
EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments
For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging... 
Via Benzinga
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17 
Via Benzinga
Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16 
Via Benzinga
Christian Angermayer Buys 1 Million Shares Of Atai Life, His Own Company
Christian Angermayer, founder and chairman of Atai Life Sciences (Nasdaq: ATAI), told Twitter that he bought 1 million shares of his ... 
Via Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14 
Via Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS: 
Via Benzinga
These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)
What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported... 
Via Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS: 
Via Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18 
Via Benzinga
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into... 
Via Benzinga
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86 
Via Benzinga
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27 
Via Benzinga
ATAI Life Sciences's Return On Capital Employed Insights
ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27... 
Via Benzinga
This Biotech Company Is Landing Ketamine-Assisted Therapy In England's Capital
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. As it pushes ahead with expansion into the United States,... 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46 
Via Benzinga
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
atai Life Sciences N.V. (NASDAQ: ATAI) has announced its financial results for the fourth quarter and full year ended December 31, ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42 
Via Benzinga
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.